NCBiotech News

We work hard to bring you the stories about the life science community in North Carolina. Every once in a while, we add a little news of our own. Read some of those stories below, or check out some of our perspectives on our staff blog.

Gilead logo
Gov. Roy Cooper announced today that California-based biopharmaceutical company Gilead Sciences, Inc. (Nasdaq; GILD), will invest up to $5 million to establish a 275-employee business services and information technology hub in Wake County.
ECU Life Science and Biotechnology Building
The Golden LEAF Foundation has awarded nearly $1.9 million to help East Carolina University expand its burgeoning pharmaceutical manufacturing workforce training program.
NCDC logo
Twenty-nine technology companies across North Carolina – about half of them working in the life sciences – have received One North Carolina program grants totaling $1.5 million.
LifeFlow device
Frost & Sullivan has named Durham’s 410 Medical as the 2021 Entrepreneurial Company of the Year in the global fluid resuscitation devices industry.
Shutterstock image of berries
Pairwise, an agricultural biotechnology company that applies gene-editing techniques to food crops, has raised $90 million in funding as it eyes commercialization of its first product next year.
The North Carolina Biotechnology Center awarded 17 grants and loans totaling more than $1.4 million to universities, biosciences companies and other entities in the second quarter of its fiscal year.
Park Point rendering of Charles River site
Charles River Laboratories, a large Massachusetts-headquartered contract research organization, is expanding its footprint in North Carolina.
Novozymes entry
Novozymes, the world’s largest industrial biotechnology company with U.S. headquarters in North Carolina, is branching out into “pest control agritechnology” through a development agreement with FMC.
Light on back of throat illustration
Durham medical device company EmitBio has reported positive clinical trial results for its initial 31-patient test of its device that works like a flashlight to shine safe, visible LED light into the throat to attack bad bugs, including SARS-CoV-2, the coronavirus causing COVID-19.
Mzuzu, Malawi children
A year-old RTP nonprofit, Med Aditus International, founded by retired UNC pharmacy prof Dhiren R. Thakker, Ph.D., is about to launch a game-changing pharmaceutical manufacturing and training initiative to provide affordable, high-quality medicines in sub-Saharan Africa.
Knee photo
Durham's Bioventus has filed regulatory paperwork outlining a preliminary $100 million target for a proposed initial public stock offering
Healthy grape leaves treated with Evoca
Belgian food and crop protection company Biotalys NV, with U.S. headquarters in NCBiotech's Landing Pad offices, has just submitted its first product for U.S. Environmental Protection Agency approval.
Shutterstock image of gene snip
Durham's Precision Biosciences has received FDA approval to advance its new drug for patients with relapsed/refractory non-Hodgkin Lymphoma.
Chimerix logo
Durham-based Chimerix priced the stock offering late Wednesday, selling more than 11.7 million shares for $8.50 apiece to raise $100 million that can help bring lead drugs to FDA approval.
Target RWE logo
Target RWE, a clinical data company based in Durham, has acquired a neighboring software analysis and services company, NoviSci, and scored an investment from California biotech pioneer Amgen.